251 related articles for article (PubMed ID: 24657661)
41. Effect of bone marrow mesenchymal stem cells from blastic phase chronic myelogenous leukemia on the growth and apoptosis of leukemia cells.
Han Y; Wang Y; Xu Z; Li J; Yang J; Li Y; Shang Y; Luo J
Oncol Rep; 2013 Aug; 30(2):1007-13. PubMed ID: 23733230
[TBL] [Abstract][Full Text] [Related]
42. Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells.
Supper E; Tahir S; Imai T; Inoue J; Minato N
PLoS One; 2015; 10(7):e0134026. PubMed ID: 26218064
[TBL] [Abstract][Full Text] [Related]
43. Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Cell Commun Signal; 2018 Apr; 16(1):13. PubMed ID: 29625612
[TBL] [Abstract][Full Text] [Related]
44. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai K; Halpern J; ten Hoeve J; Rao X; Sawyers CL
Oncogene; 1996 Jul; 13(2):247-54. PubMed ID: 8710363
[TBL] [Abstract][Full Text] [Related]
45. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
[TBL] [Abstract][Full Text] [Related]
46. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
[TBL] [Abstract][Full Text] [Related]
47. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment.
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Sep; 24(9):1883-8. PubMed ID: 22659137
[TBL] [Abstract][Full Text] [Related]
48. Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.
Tan Z; Peng A; Xu J; Ouyang M
BMC Anesthesiol; 2017 Sep; 17(1):132. PubMed ID: 28962554
[TBL] [Abstract][Full Text] [Related]
49. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
50. Osteopontin is upregulated by BCR-ABL.
Flamant S; Kortulewski T; Dugray A; Bonnet ML; Guillier M; Guilhot F; Bourhis JH; Vainchenker W; Tronik-Le Roux D; Turhan AG
Biochem Biophys Res Commun; 2005 Aug; 333(4):1378-84. PubMed ID: 15993098
[TBL] [Abstract][Full Text] [Related]
51. Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis.
Yang X; Pang J; Shen N; Yan F; Wu LC; Al-Kali A; Litzow MR; Peng Y; Lee RJ; Liu S
Oncotarget; 2016 Jun; 7(24):36382-36394. PubMed ID: 27144331
[TBL] [Abstract][Full Text] [Related]
52. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
53. RNA trafficking by acute myelogenous leukemia exosomes.
Huan J; Hornick NI; Shurtleff MJ; Skinner AM; Goloviznina NA; Roberts CT; Kurre P
Cancer Res; 2013 Jan; 73(2):918-29. PubMed ID: 23149911
[TBL] [Abstract][Full Text] [Related]
54. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells.
Aman MJ; Rudolf G; Goldschmitt J; Aulitzky WE; Lam C; Huber C; Peschel C
Blood; 1993 Oct; 82(8):2371-8. PubMed ID: 8400288
[TBL] [Abstract][Full Text] [Related]
55. Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo.
Shirasaki R; Tashiro H; Oka Y; Matsuo T; Yamamoto T; Sugao T; Akiyama N; Kawasugi K; Shirafuji N
J Oncol; 2012; 2012():901783. PubMed ID: 22848221
[TBL] [Abstract][Full Text] [Related]
56. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.
Yamaguchi T; Kawamoto E; Gaowa A; Park EJ; Shimaoka M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668652
[TBL] [Abstract][Full Text] [Related]
57. Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Ho M; Chen T; Liu J; Dowling P; Hideshima T; Zhang L; Morelli E; Camci-Unal G; Wu X; Tai YT; Wen K; Samur M; Schlossman RL; Mazitschek R; Kavanagh EL; Lindsay S; Harada T; McCann A; Anderson KC; O'Gorman P; Bianchi G
Leukemia; 2020 Jan; 34(1):196-209. PubMed ID: 31142847
[TBL] [Abstract][Full Text] [Related]
58. Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progression.
Karantanou C; Minciacchi VR; Kumar R; Zanetti C; Bravo J; Pereira RS; Tascher G; Tertel T; Covarrubias-Pinto A; Bankov K; Pfeffermann LM; Bonig H; Divieti-Pajevic P; McEwan DG; Giebel B; Münch C; Dikic I; Krause DS
Blood Adv; 2023 Apr; 7(7):1190-1203. PubMed ID: 36044386
[TBL] [Abstract][Full Text] [Related]
59. The regulatory role of exosomes in leukemia and their clinical significance.
Deng W; Wang L; Pan M; Zheng J
J Int Med Res; 2020 Aug; 48(8):300060520950135. PubMed ID: 32840158
[TBL] [Abstract][Full Text] [Related]
60. Exosome-mediated cellular crosstalk within the tumor microenvironment upon irradiation.
He C; Li L; Wang L; Meng W; Hao Y; Zhu G
Cancer Biol Med; 2021 Feb; 18(1):21-33. PubMed ID: 33628582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
